CMS Issues Second Wave of Changes in Response to COVID-19

On April 30, CMS issued its second round of regulatory waivers and changes to increase access to testing and provide greater flexibilities to support care delivery in the wake of COVID-19, including for telehealth services, hospitals, ACOs, home health, and therapists. Click to read more.

FY 2021 Proposed Rule for IPFs

CMS indicates that they are proposing rules with minimal policy changes in order to alleviate regulatory burden on providers due to COVID19. This brief summarizes the FY 2021 proposed rule for Inpatient Psychiatric Facilities (IPFs). Click to read more.

Market Response to Coronavirus Heating Up – 200 Surveyed Report Challenges, Emerging Strategies

The Coronavirus is dramatically affecting the way healthcare is administered in the US forcing hospitals and physician groups to make tough decisions about who they see and who they don’t, but it’s also giving way to innovation and collaboration that may represent some hope and a path to a new era in healthcare delivery. Our health policy and market research group on Tuesday surveyed 200 healthcare leaders who are literally in the throes of crisis management, representing a sample of the nation’s leading systems, payers and physician groups and ‘on the ground’ clinical teams. We will be...

CMS Announces First Approval of Serious Mental Illness Waiver

On November 6th, CMS announced the approval of DC’s Medicaid 1115 Waiver that expands access to behavioral health treatment. This waiver, which will go into effect on January 1, 2020, will broaden services available to beneficiaries diagnosed with serious mental illness (SMI) or serious emotional disturbance (SED) and provide new services for beneficiaries diagnosed with substance use disorder (SUD). Click to read more.